NS · Pharmaceuticals

Aurobindo Pharma Ltd (AUROPHARMA)

Pharmaceuticals & Biotechnology

Aurobindo Pharma Ltd (AUROPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $891.41B, P/E ratio is 36.91, net margin is 17.8%, dividend yield is 0.26%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AUROPHARMA

Market cap

$891.41B

P/E ratio

36.91

Net margin

17.8%

Dividend yield

0.26%

Aurobindo Pharma Ltd (AUROPHARMA) — FAQ

What is Aurobindo Pharma Ltd's market cap?

Aurobindo Pharma Ltd (AUROPHARMA) has a reported market cap of $891.41B (data as of 2026-07-10).

What is AUROPHARMA's P/E ratio?

The price-to-earnings (P/E) ratio for Aurobindo Pharma Ltd (AUROPHARMA) is 36.91 (data as of 2026-07-10).

Does Aurobindo Pharma Ltd pay a dividend?

Aurobindo Pharma Ltd (AUROPHARMA) shows a reported dividend yield of 0.26%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Aurobindo Pharma Ltd in?

Aurobindo Pharma Ltd (AUROPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is AUROPHARMA listed on?

AUROPHARMA is listed on NS.

What is Aurobindo Pharma Ltd's net margin?

Aurobindo Pharma Ltd (AUROPHARMA) reports a net margin of 17.8% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)